Arbor Pharmaceuticals was acquired by Azurity Pharmaceuticals, a specialty pharmaceutical company focused on developing innovative prescription medications for patients with unique medical needs. The strategic transaction established Arbor as a wholly owned subsidiary of Azurity, effectively combining their corporate footprints, product portfolios, and commercial distribution networks. The integration united Azurity's expertise in liquid formulations with Arbor's established presence in neurology and specialty therapeutics.